在Y系聚合酶中的乌比基结合域调节转化合成
Marzena Bienko1, Catherine M Green, Nicola Crosetto
1Institute for Biochemistry II, Goethe University Medical School, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
概括
研究人员在Y-家族聚合酶中发现了在DNA损伤中转化合成 (TLS) 所必不可少的泛素结合域. 这些域促进聚合酶招募和DNA修复,这对于细胞对DNA损伤的反应至关重要.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 转载合成 (TLS) 是哺乳动物细胞中关键的DNA修复途径,可以在DNA损伤中进行复制.
- 众所周知,增殖细胞核抗原 (PCNA) 的ubiquitination可以在DNA损伤时将复制机制直接导向TLS途径.
- 细胞在TLS中识别和解释PCNA无处不在的精确机制仍然不完全理解.
研究的目的:
- 在转化合成过程中识别和表征涉及无化PCNA识别的新型蛋白质域.
- 阐明这些域在Y家族DNA聚合酶的招募和活性中的功能意义.
主要方法:
- 在Y家族TLS聚合酶中识别保存的泛素结合域 (UBM和UBZ).
- 生物化学试验,以评估聚合酶与乌比奎和单乌比奎PCNA的结合.
- 细胞局部化研究,观察复制工厂中的聚合酶积累.
- 功能补充测定在色素变体 (XP-V) 纤维细胞中.
主要成果:
- 在Y-家族TLS聚合酶中发现了两个进化保守的泛素结合域,UBM和UBZ.
- 这些域调节聚合酶eta (poleta) 和iota (poliota) 与ubiquitin的结合.
- 已识别的域对于这些聚合酶在复制工厂的积累及其与单基化PCNA的相互作用至关重要.
- 波尔塔的UBZ域对于恢复XP-V细胞正常的紫外线 (UV) 辐射反应至关重要.
结论:
- 在Y家族聚合酶中的乌比基结合域 (UBM和UBZ) 是转化合成途径的关键调节者.
- 这些域促进TLS聚合酶通过与单基化PCNA相互作用而被招募到DNA病变中.
- 这些发现为控制DNA损伤耐受性和修复的分子机制提供了关键的见解.
相关概念视频
Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
Catalytically Perfect Enzymes
The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Tagging and Fusion Proteins
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


